Factor Analysis of Predicting Cardiovascular Death in the Remote Period after Myocardial Revascularization

Ekaterina S. Levitskaya¹*, PhD; Mikhail M. Batiushin¹, PhD, ScD; Elena O. Golovinova¹; Valentina V. Gul'chenko¹; Vladimir A. Chistjakov¹, ²; Dmitriy G. Pasechnik¹

¹Rostov State Medical University, ²Southern Federal University; Rostov-on-Don, Russia

*Corresponding author: Ekaterina S. Levitskaya, PhD. Rostov State Medical University, Rostov-on-Don, Russia.  E-mail: es.med@mail.ru

Published: September 12, 2015. DOI: 10.21103/Article5(3)_OA1


The aim of the present study was to analyze the impact of traditional and renal risk factors (RFs) on the probability of cardiovascular death in CHD patients in the remote period after myocardial revascularization (MR).

Materials and Methods: The present study included 90 CHD patients (80 men and 10 women; mean age 56.1±0.9 years) with indications for MR. The prevalence of major cardiovascular RFs (old age, gender, duration of CHD, arterial hypertension, diabetes mellitus, another localization of atherosclerotic lesions, and the presence and duration of smoking) and the main echocardiographic parameters and the parameters of renal function  (MAU and GFR) were assessed. Fatal cardiovascular outcomes were the only endpoint of the study.

 Results: Cardiovascular death (CVD) occurred in 10/12.3% patients. The studied RFs, such as the patient's age, duration of smoking, and presence of angina with low tolerance to physical stress, had a significant impact on the probability of death in CHD patients. Risk of CVD (rCVD) over a long-term period increases by 18.1% in patients with elevated levels of total cholesterol, by 16.2% in patients with stable angina pectoris class III, by 50.5% in patients with atherosclerotic lesions of lower limb and cerebral arteries, and by 69.3% in patients suffering from overweight. Left atrial size, LVPWT, and LVMI were also significant predictors of adverse cardiovascular prognosis. The increase in the number of coronary arteries with clinically significant stenosis, including subtotal narrowing of the vessel lumen, increases rCVD in the long-term period. The important role of a highly reliable level of glucose in the urine for the risk score was found. The presence of CKD stage 3 and the impaired GFR also significantly increased rCVD.

Conclusion: Our data demonstrate a high medical and social importance of a comprehensive and integrated analysis not only of traditional RFs, but also of markers of renal dysfunction in risk stratification of cardiovascular prognosis in CHD patients.

coronary heart disease; myocardial revascularization; risk factors; prognosis.
  1. Hussain SM, Oldenburg B, Wang Y, Zoungas S, Tonkin AM. Assessment of Cardiovascular Disease Risk in South Asian Populations. Int J Vasc Med. 2013; 2013:786801. doi: 10.1155/2013/786801.
  2. Laffey JG, Talmor D. Predicting the development of acute respiratory distress syndrome: searching for the “Troponin of ARDS”. Am J Respir Crit Care Med. 2013; 187(7):671-2.
  3. García-Donaire JA, Ruilope LM. Cardiovascular and Renal Links along the Cardiorenal Continuum. Int J Nephrol. 2011; 2011:975782. doi: 10.4061/2011/975782.
  4. Slee AD. Exploring metabolic dysfunction in chronic kidney disease. Nutr Metab (Lond). 2012; 9(1):36. doi: 10.1186/1743-7075-9-36.
  5. Osuji CU, Nwaneli CU, Onwubere BJ, Onwubuya EI, Ahaneku GI. Renal function in patients with hypertension associated congestive cardiac failure seen in a tertiary hospital. Int J Nephrol. 2012; 2012:769103. doi: 10.1155/2012/769103.
  6. Smith GL, Shlipak MG, Havranek EP, Masoudi FA, WM McClellan, Foody JM, et al. Race and renal impairment in heart failure: mortality in blacks versus whites. Circulation. 2005; 111(10):1270-7.
  7. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M,et al. Heart disease and stroke statistics – 2015 update: a report from the American Heart Association. Circulation. 2015; 131(4):e29-322.
  8. Ao H, Wang X, Xu F,  Zheng Z, Chen M,  Li L, et al. The impact of body mass index on short- and long-term outcomes in patients undergoing coronary artery graft bypass. PLoS One. 2014; 9(4):e95223. doi: 10.1371/journal.pone.0095223.
  9. Chen T, Li W, Wang Y, Xu B, Guo J. Smoking status on outcomes after percutaneous coronary intervention. Clin Cardiol. 2012; 35(9):570-4.
  10. Rallidis LS, Lekakis J,  Panagiotakos D,  Fountoulaki K, Komporozos C, Apostolou T,  et.al. Long-term prognostic factors of young patients (<or=35 years) having acute myocardial infarction: the detrimental role of continuation of smoking. Eur J Cardiovasc Prev Rehabil. 2008; 15(5):567-71.
  11. Cohen DJ, Doucet M, Cutlip DE,  Ho KKL, Popma JJ, Kuntz RE, et al. Impact of smoking on clinical and angiographic restenosis after percutaneous coronary intervention: another smoker’s paradox?  Circulation. 2001; 104(7):773-8.
  12. Sherif MA, Nienaber CA, Toelg R, Abdel-Wahab M, Geist V, Schneider S, et al. Impact of smoking on the outcome of patients treated with drug-eluting stents: 1-year results from the prospective multicentre German Drug-Eluting Stent Registry (DES.DE). Clin Res Cardiol. 2011; 100(5):413-23.
  13. Aldweib N, Negishi K, Hachamovitch R, Jaber WA,  Seicean S, Marwick TH. Impact of repeat myocardial revascularization in silent ischemia after previous revascularization. J Am Coll Cardiol. 2013; 61(15):1616-23.
  14. Curtis LT. Understanding the kidneys' role in blood glucose regulation. Am J Manag Care. 2012; 18(1):11-6.
  15. Teresa SMT, Walter PA, Marion EB,  Miyasaka Y,  Gersh B J, Bailey KR, et al. Prediction of cardiovascular outcomes with left atrial size : is volume superior to area or diameter? J Am Coll Cardiol. 2006; 47(5):1018-23.
  16. Tsang TS, Barnes ME, Gersh BJ, Bailey KR, Seward JB. Risks for atrial fibrillation and congestive heart failure in patients >/= 65 years of age with abnormal left ventricular diastolic relaxation. Am J Cardiol. 2004; 93(1):54-8.
  17. Moller JE, Hillis GS, Oh JK,  Seward JB, Reeder GS, Wright RS, et al. Left atrial volume: a powerful predictor of survival after acute myocardial infarction. Circulation. 2003; 107(17):2207-12.
  18. Barnes ME, Miyasaka Y, Seward JB, Gersh BJ, Rosales AG, Bailey KR, et al. Left atrial volume in the prediction of first ischemic stroke in an elderly cohort without atrial fibrillation. Mayo Clin Proc. 2004; 79:1008-14.
  19. Bergeron S,  Møller JE,  Bailey KR, Horng HC,  John CB, Pellikka PA. Exertional changes in circulating cardiac natriuretic peptides in patients with suggested coronary artery disease. J Am Soc Echocardiogr. 2006; 19(6):772-6.
  20. Bouzas-Mosquera A, Broullón FJ, Álvarez-García N,  Peteiro J,  Mosquera VX, Castro-Beiras A. Association of left ventricular mass with all-cause mortality, myocardial infarction and stroke. PLoS One. 2012; 7(9): e45570. doi: 10.1371/journal.pone.0045570.
  21. Batiushin MM, Levickaja ES, Terent'ev VP, Savis'ko AA, Djuzhikov AA, Kulikovskih JaV. Renal and coronary predictors of post-myocardial revascularization prognosis in patients with coronary heart disease. Russ J Cardiol. 2012; 6(98):45-50. [Article in Russian].
  22. Batiushin MM, Levickaja ES, Terent'ev VP, Djuzhikov AA, Poddubnyj AV. Predicting cardiovascular risk in patients with coronary artery disease who underwent myocardial revascularization, taking into account the presence of renal and cardiovascular risk factors. Klin Nefrol. 2011; 1:39-42. [Article in Russian].
  23. Bahar I, Akgul A, Ozatik MA, Vural KM, Demirbag AE, Boran M,  et al. Acute renal failure following open heart surgery: risk factors and prognosis. Perfusion. 2005; 20(6):317-22. 
  24. Felicio ML, Andrade RR, Castiglia YM, Silva MA, Vianna PT, Martins AS. Cystatin C and glomerular filtration rate in the cardiac surgery with cardiopulmonary bypass. Rev Bras Cir Cardiovasc. 2009; 24(3):305-11.

The fully formatted PDF version is available.       

Download Article

Int  J Biomed. 2015; 5(3):117-122. © 2015 International Medical Research and Development Corporation. All rights reserved.